Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 11

Adult ID

Epidemiology & Infection Control

HIV-STD-TB

Trainee

COVID
Symposium

129 - The Impact of COVID on the HIV Care Continuum

Saturday, October 2, 2021
10:00 AM - 11:15 AM EDT

    Moderator(s)

  • Wendy Armstrong, MD

    Professor of Medicine
    Emory University
    Atlanta, GA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • Albert Liu, MD, MPH

    Clinical Research Director
    Bridge HIV, San Francisco Department of Public Health, CA, United States

    Gilead Sciences (Individual(s) Involved: Self): Gilead has donated study drug for studies I have led., Grant/Research Support, Other Financial or Material Support, Research Grant or Support; IAS-USA (Individual(s) Involved: Self): Honorarium for manuscript writing, Other Financial or Material Support; Viiv Healthcare (Individual(s) Involved: Self): Grant/Research Support, Research Grant or Support

  • Barbara Taylor, MD, MS

    Associate Professor
    University of Texas Health Science Center San Antonio
    San Antonio, TX, United States

    Gilead Sciences (Individual(s) Involved: Self): Research Grant or Support

  • Ellen Eaton, MD

    Assistant Professor
    University of Alabama at Birmingham
    Birmingham, Alabama, United States

    Gilead (Individual(s) Involved: Self): Research Grant or Support

Participants should be aware of the following financial/non-financial relationships:
Wendy Armstrong, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Albert Liu, MD, MPH: Gilead Sciences (Individual(s) Involved: Self): Gilead has donated study drug for studies I have led., Grant/Research Support, Other Financial or Material Support, Research Grant or Support; IAS-USA (Individual(s) Involved: Self): Honorarium for manuscript writing, Other Financial or Material Support; Viiv Healthcare (Individual(s) Involved: Self): Grant/Research Support, Research Grant or Support
Barbara S. Taylor, MD, MS: Gilead Sciences (Individual(s) Involved: Self): Research Grant or Support
Ellen Eaton, MD : Gilead (Individual(s) Involved: Self): Research Grant or Support

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • discuss how the COVID-19 pandemic affected HIV treatment outcomes
  • assess the impact of the COVID-19 pandemic on access to HIV testing and prevention services
  • describe how people with mental health and substance use disorders have been affected by the pandemic

Presentations:

  • The Impact of COVID-19 on HIV Testing and Prevention

    Speaker: Albert Liu, MD, MPH – Bridge HIV, San Francisco Department of Public Health

  • The Impact of COVID-19 on HIV Treatment and Care

    Speaker: Barbara S. Taylor, MD, MS – University of Texas Health Science Center San Antonio

  • The Perfect Storm: COVID, Mental Health, & Substance Use Disorder in PLWH

    Speaker: Ellen Eaton, MD – University of Alabama at Birmingham